Sinovac Biotech Ltd. (Nasdaq: SVA) announced today that the underwriters of its previously announced public common share offering have exercised ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE